Position in BDTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,203,104
+$577,056 QoQ
Shares Held
564,838
+119.2% QoQ
Ownership
0.986%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. BDTX ranks #236 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in BDTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,203,104 | 564,838 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $626,048 | 257,633 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,381,696 | 628,416 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $777,975 | 313,700 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $198,079 | 127,794 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $106,770 | 49,893 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $167,287 | 38,457 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $123,648 | 26,534 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,653 | 4,271 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,203 | 3,987 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $706 | 246 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $43,020 | 8,519 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $6,179 | 3,433 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $9,083 | 5,375 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $43,293 | 17,599 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $57,671 | 20,820 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $157,522 | 29,554 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $142,304 | 16,821 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $138,563 | 11,367 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,047,765 | 43,189 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $5,955 | 197 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $196,212 | 4,654 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $180,413 | 7,231 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||